MedTrace Logo

Conscious Sedation Efficacy of the MKO Melt (Midazolam, Ketamine, Ondansetron)

NCT03653520 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 651

Last updated 2018-08-31

No results posted yet for this study

Summary

The investigators hypothesized that the combination of Valium, Tramadol and Zofran is superior to the substantially more expensive MKO melt in patient satisfaction after cataract surgery.

Conditions

  • Cataract

Interventions

DRUG

Diazepam

5 or 10mg

DRUG

Tramadol

50mg or 100mg

DRUG

Ondansetron

1 or two tabs

DRUG

MKO melt

1 or 2 MKO melts

Sponsors & Collaborators

  • Avanti Anesthesia

    lead OTHER

Principal Investigators

  • Maggie Jeffries, MD · Avanti Anesthesia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-06-28
Primary Completion
2017-11-02
Completion
2017-11-04

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03653520 on ClinicalTrials.gov